Teeth and bones are among the hardest structures in the human body, but certain inherited conditions can rob them of that ...

Keros reported a net loss of $28.7 million in the second quarter of 2026 as compared to a net loss of $30.7 million in the second quarter of 2025. The decrease of $2.0 million was primarily due to ...

The patient's genetic disorder causes frequent seizures and developmental delays. His progress, along with that of another ...

To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru Inc. call. An archived version of the audio webcast will be ...

Pubertal suppression has been flagged as a time of skeletal vulnerability among transgender and gender-diverse adolescents. A ...

A baby can inherit one healthy copy of TBX5 and still develop serious heart defects if the other copy does not work. That genetic imbalance is one cause of congenital heart disease, the most common ...

(Artur Plawgo/Science Photo Library/Getty Images) A rare and potentially fatal genetic disease marked by weakened bones is ...

The gut microbiota has emerged as a key regulator of endocrine, metabolic, and immune homeostasis, influencing numerous ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

Researchers identify AXL receptor tyrosine kinase as a key regulator of bone formation, revealing a promising new ...

Osteoporosis is one of the most common age-related bone diseases, affecting millions of people worldwide and increasing the ...